Cargando...
Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer
The large family of costimulatory molecules plays a crucial role in regulation of the immune response. These molecules modulate TCR signalling via phosphorylation cascades. Some of the coinhibitory members of this family, such as PD-1 and CTLA-4, already constitute approved targets in cancer therapy...
Guardado en:
| Publicado en: | ESMO Open |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMJ Publishing Group
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5518304/ https://ncbi.nlm.nih.gov/pubmed/28761757 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2017-000213 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|